(1) Included three months of Entropic operations.
(2) Included two months of Entropic operations.
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
Nine Months Ended | |||||||
September 30, 2015 (1) | September 30, 2014 | ||||||
Net revenue | $ | 201,411 | $ | 100,634 | |||
Cost of net revenue | 101,748 | 38,426 | |||||
Gross profit | 99,663 | 62,208 | |||||
Operating expenses: | |||||||
Research and development | 62,765 | 41,944 | |||||
Selling, general and administrative | 60,021 | 24,590 | |||||
Restructuring charges | 11,814 | — | |||||
Total operating expenses | 134,600 | 66,534 | |||||
Loss from operations | (34,937 | ) | (4,326 | ) | |||
Interest income | 168 | 182 | |||||
Other income (expense), net | 351 | (79 | ) | ||||
Loss before income taxes | (34,418 | ) | (4,223 | ) | |||
(Benefit) provision for income taxes | (631 | ) | 456 | ||||
Net loss | $ | (33,787 | ) | $ | (4,679 | ) | |
Net loss per share: | |||||||
Basic | $ | (0.67 | ) | $ | (0.13 | ) | |
Diluted | $ | (0.67 | ) | $ | (0.13 | ) | |
Shares used to compute net loss per share: | |||||||
Basic | 50,528 | 36,127 | |||||
Diluted | 50,528 | 36,127 |
___________________________________________
(1) Included five months of Entropic operations.
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Three Months Ended | |||||||||||
September 30, 2015 | June 30, 2015 | September 30, 2014 | |||||||||
Operating Activities | |||||||||||
Net income (loss) | $ | 1,582 | $ | (30,647 | ) | $ | (3,205 | ) | |||
Adjustments to reconcile net loss to cash provided by operating activities: | |||||||||||
Amortization and depreciation | 17,296 | 12,227 | 1,322 | ||||||||
Amortization of investment premiums, net | 57 | 55 | 168 | ||||||||
Amortization of inventory step-up | 958 | 13,286 | — | ||||||||
Stock-based compensation | 5,032 | 6,301 | 4,002 | ||||||||
Deferred income taxes | 251 | (1,960 | ) | — | |||||||
Gain on disposal of property and equipment | (39 | ) | — | — | |||||||
Loss on sale of available-for-sale securities | 21 | — | — | ||||||||
Impairment of long-lived assets | 153 | — | 8 | ||||||||
Impairment of lease | 568 | 5,593 | — | ||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | (205 | ) | 8,319 | 233 | |||||||
Inventory | 1,581 | (9,659 | ) | 187 | |||||||
Prepaid and other assets | (2,684 | ) | 3,800 | (60 | ) | ||||||
Accounts payable, accrued expenses and other current liabilities | (9,370 | ) | (2,530 | ) | (1,086 | ) | |||||
Accrued compensation | 3,342 | (371 | ) | 1,461 | |||||||
Deferred revenue and deferred profit | 3 | 502 | 2,256 | ||||||||
Accrued price protection liability | 3,925 | (372 | ) | 973 | |||||||
Other long-term liabilities | (513 | ) | 90 | 102 | |||||||
Net cash provided by operating activities | 21,958 | 4,634 | 6,361 | ||||||||
Investing Activities | |||||||||||
Purchases of property and equipment | 103 | (436 | ) | (3,126 | ) | ||||||
Purchases of intangible assets | (100 | ) | — | — | |||||||
Cash used in acquisition, net of cash acquired | — | (3,615 | ) | — | |||||||
Purchases of available-for-sale securities | (25,712 | ) | (3,815 | ) | (6,693 | ) | |||||
Maturities of available-for-sale securities | 4,400 | 36,918 | 6,900 | ||||||||
Net cash (used in) provided by investing activities | (21,309 | ) | 29,052 | (2,919 | ) | ||||||
Financing Activities | |||||||||||
Repurchases of common stock | — | (101 | ) | — | |||||||
Net proceeds from issuance of common stock | 2,891 | 3,207 | 25 | ||||||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (1,367 | ) | (2,896 | ) | (653 | ) | |||||
Equity issuance costs | — | (8 | ) | — | |||||||
Net cash provided by (used in) financing activities | 1,524 | 202 | (628 | ) | |||||||
Effect of exchange rate changes on cash and cash equivalents | (755 | ) | 74 | (7 | ) | ||||||
Increase in cash and cash equivalents | 1,418 | 33,962 | 2,807 | ||||||||
Cash and cash equivalents at beginning of period | 56,731 | 22,769 | 31,248 | ||||||||
Cash and cash equivalents at end of period | $ | 58,149 | $ | 56,731 | $ | 34,055 |